ES2178675T3 - Agente estimulante del tejido duro. - Google Patents

Agente estimulante del tejido duro.

Info

Publication number
ES2178675T3
ES2178675T3 ES95926565T ES95926565T ES2178675T3 ES 2178675 T3 ES2178675 T3 ES 2178675T3 ES 95926565 T ES95926565 T ES 95926565T ES 95926565 T ES95926565 T ES 95926565T ES 2178675 T3 ES2178675 T3 ES 2178675T3
Authority
ES
Spain
Prior art keywords
fabric
stimulating agent
hard fabric
regeneration
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95926565T
Other languages
English (en)
Inventor
Hans-Arne Hansson
Gunilla Johansson-Ruden
Olle Larm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicarb AB
Original Assignee
Medicarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb AB filed Critical Medicarb AB
Application granted granted Critical
Publication of ES2178675T3 publication Critical patent/ES2178675T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USO DE QUITOSANO Y UN POLISACARIDO INMOVILIZADO AL MISMO SELECCIONADO A PARTIR DE HEPARINA, SULFATO DE HEPARANO, CONDROITINSULFATOS Y SULFATO DE DEXTRANO PARA LA FABRICACION DE UN AGENTE CAPAZ DE PROPORCIONAR LA REGENERACION ESTIMULADA DE TEJIDO DURO; PROCESO PARA ESTIMULAR LA REGENERACION DE TEJIDO DURO EN CONEXION CON LA LLAMADA OSTEOINTEGRACION; E IMPLANTE PENSADO PARA LA INTEGRACION DE TEJIDO DURO, ESPECIALMENTE TEJIDO OSEO.
ES95926565T 1994-07-19 1995-07-13 Agente estimulante del tejido duro. Expired - Lifetime ES2178675T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402528A SE9402528D0 (sv) 1994-07-19 1994-07-19 Hårdvävnadsstimulerande med el

Publications (1)

Publication Number Publication Date
ES2178675T3 true ES2178675T3 (es) 2003-01-01

Family

ID=20394768

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95926565T Expired - Lifetime ES2178675T3 (es) 1994-07-19 1995-07-13 Agente estimulante del tejido duro.

Country Status (22)

Country Link
US (1) US5894070A (es)
EP (1) EP0771206B1 (es)
JP (1) JP3492377B2 (es)
KR (1) KR100395724B1 (es)
CN (1) CN1081923C (es)
AT (1) ATE219678T1 (es)
BR (1) BR9508322A (es)
CA (1) CA2194462C (es)
CZ (1) CZ289981B6 (es)
DE (1) DE69527203T2 (es)
DK (1) DK0771206T3 (es)
ES (1) ES2178675T3 (es)
FI (1) FI970202A7 (es)
HU (1) HU220770B1 (es)
IS (1) IS1793B (es)
MX (1) MX9700443A (es)
NO (1) NO310223B1 (es)
NZ (1) NZ290219A (es)
PL (1) PL181764B1 (es)
RU (1) RU2153877C2 (es)
SE (1) SE9402528D0 (es)
WO (1) WO1996002259A1 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el
KR100237738B1 (ko) * 1997-04-26 2000-01-15 이용찬 생채 매식용 의료기구 임플란트의 기능 향상방법
DE19724869C2 (de) * 1997-06-12 1999-05-12 Henkel Kgaa Verwendung von Citosanderivaten zur Oberflächenbeschichtung
EP0899247B1 (en) * 1997-08-28 2002-11-06 Ngk Spark Plug Co., Ltd Calcium phosphate cement and calcium phosphate cement composition
JP4215884B2 (ja) * 1998-03-23 2009-01-28 日本特殊陶業株式会社 リン酸カルシウムセメント及びリン酸カルシウムセメント組成物
US20030147860A1 (en) * 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
CA2335058A1 (en) 1998-06-22 1999-12-29 Danforth Joslyn Method, implant and delivery system for enhancing blood flow in tissue
JP4606586B2 (ja) * 1998-11-10 2011-01-05 株式会社ネーテック 機能性キトサン誘導体
FR2791262B1 (fr) * 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
WO2001000792A1 (en) 1999-06-29 2001-01-04 Marchosky J Alexander Compositions and methods for forming and strengthening bone
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
FI19991852A7 (fi) 1999-09-01 2001-03-02 Yli Urpo Antti Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
AU1375301A (en) * 1999-11-15 2001-05-30 Bio Syntech Canada Inc Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
ATE243049T1 (de) * 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
KR100880622B1 (ko) * 2000-06-29 2009-01-30 바이오신텍 캐나다 인코포레이티드 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법
ES2169681B1 (es) * 2000-08-10 2003-10-01 Osfarma S L Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones.
AU2002221370A1 (en) * 2000-11-15 2002-05-27 Bio Syntech Canada Inc Method for restoring a damaged or degenerated intervertebral disc
RU2212243C2 (ru) * 2001-06-15 2003-09-20 Щиголева Светлана Александровна Препарат "сха" для лечения кожных заболеваний
ES2353116T3 (es) * 2002-07-16 2011-02-25 Bio Syntech Canada Inc. Composiciones para disoluciones de quitosano citocompatibles, inyectables, autogelificantes para encapsular y administrar células vivas o factores biológicamente activos.
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
FR2844717B1 (fr) * 2002-09-23 2006-07-07 Richard Cancel Plaque de renfort comprenant notamment du chitosane
RU2294751C2 (ru) * 2002-09-30 2007-03-10 Реджен Байотек, Инк. Композиция для стимулирования образования костной ткани и сращения кости
JP2006515765A (ja) * 2002-11-15 2006-06-08 エスディージーアイ・ホールディングス・インコーポレーテッド 滑膜性関節を治療するためのコラーゲンベース材料および方法
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
DE10338110A1 (de) * 2003-08-15 2005-03-10 Biomet Deutschland Gmbh Mit Chitosan beschichteter metallischer Gegenstand sowie Verfahren zu dessen Herstellung
CA2535169A1 (en) * 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
FR2866571B1 (fr) * 2004-02-20 2007-09-21 Philippe Zanchetta Utilisation d'un melange de polysaccharides specifiques denomme par l'inventeur ezbone, comprenant de l'acide hyaluronique, de la chondroitine 6 sulfate, du dermatane sulfate et de l'heparine en cicatrisation osseuse.
CA2565913A1 (en) * 2004-05-07 2005-11-17 The University Of Queensland Composition for stimulating bone growth and differentiation and method for isolating same
AU2005239977B2 (en) * 2004-05-07 2010-11-11 The University Of Queensland Composition for stimulating bone growth and differentiation and method for isolating same
KR101322889B1 (ko) 2004-08-16 2013-10-30 셀리서치 코포레이션 피티이 리미티드 제대의 양막으로부터 줄기/전구세포의 추출
EP1838335A1 (en) * 2005-01-19 2007-10-03 Bonoss Medical AB Growth factor composition
EP1937326B1 (en) 2005-10-21 2018-09-12 CellResearch Corporation Pte Ltd Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
CA2627907C (en) * 2005-11-01 2014-06-17 Osteotech, Inc. Osteoinductive composition comprising osteoinductive factors recovered from mineralized bone and a carrier
WO2007051311A1 (en) * 2005-11-04 2007-05-10 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
EP1977739A1 (en) * 2007-04-03 2008-10-08 Bioiberica, S.A. Nanoparticulate composition of chitosan and chondroitin sulfate
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
CA3062443C (en) * 2007-06-15 2022-03-15 Warsaw Orthopedic, Inc. Method of treating tissue
CA2690457C (en) 2007-06-15 2018-02-20 Osteotech, Inc. Bone matrix compositions and methods
WO2008157492A2 (en) * 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
US9358113B2 (en) * 2007-07-10 2016-06-07 Warsaw Orthopedic, Inc. Delivery system
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
EP2211921B1 (en) * 2007-10-19 2013-12-25 Warsaw Orthopedic, Inc. Demineralized bone matrix compositions and methods
GB2463474B (en) 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
RU2383564C1 (ru) * 2008-11-21 2010-03-10 Астемир Икрамович Шайхалиев Композиция - остеоиндуктор и остеокондуктор, при лечении костной патологии в стоматологии и челюстно-лицевой хирургии, и способ получения композиции - остеоиндуктора и остеокондуктора, при лечении костной патологии в стоматологии и челюстно-лицевой хирургии
WO2010093955A1 (en) * 2009-02-12 2010-08-19 Osteotech,Inc. Segmented delivery system
CN104039356B (zh) 2012-01-27 2018-08-17 弗·哈夫曼-拉罗切有限公司 用于靶向递送的、与小分子整联蛋白拮抗剂共价连接的壳聚糖
WO2014152796A2 (en) 2013-03-14 2014-09-25 Hemcon Medical Technologies, Inc. Biocompatible and bioabsorbable derivatized chitosan compositions
CN105126165B (zh) * 2015-01-21 2017-12-08 中国人民解放军第三〇七医院 一种钛牙种植体材料及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL163522B (nl) * 1970-07-20 1980-04-15 Montedison Spa Werkwijze om een katalysator te bereiden voor de polymerisatie van alkenen-1.
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5256447A (en) * 1991-12-31 1993-10-26 Minnesota Mining And Manufacturing Company Adhesive composition and method
BR9207010A (pt) * 1991-12-31 1995-12-05 Minnesota Mining & Mfg Composição adesiva e processo de aderência de um material restaurador a um substrato
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el

Also Published As

Publication number Publication date
IS1793B (is) 2001-12-12
RU2153877C2 (ru) 2000-08-10
HU220770B1 (hu) 2002-05-28
NO970215D0 (no) 1997-01-17
CN1157568A (zh) 1997-08-20
FI970202A0 (fi) 1997-01-17
JPH10502664A (ja) 1998-03-10
DE69527203D1 (de) 2002-08-01
HUT77607A (hu) 1998-06-29
ATE219678T1 (de) 2002-07-15
PL318326A1 (en) 1997-06-09
IS4409A (is) 1997-01-06
FI970202L (fi) 1997-01-17
CN1081923C (zh) 2002-04-03
SE9402528D0 (sv) 1994-07-19
JP3492377B2 (ja) 2004-02-03
HU9700160D0 (en) 1997-03-28
CA2194462C (en) 2007-07-10
KR100395724B1 (ko) 2004-02-18
US5894070A (en) 1999-04-13
CA2194462A1 (en) 1996-02-01
NO310223B1 (no) 2001-06-11
EP0771206B1 (en) 2002-06-26
AU3089595A (en) 1996-02-16
DK0771206T3 (da) 2002-08-19
KR970704459A (ko) 1997-09-06
PL181764B1 (pl) 2001-09-28
MX9700443A (es) 1997-04-30
WO1996002259A1 (en) 1996-02-01
CZ289981B6 (cs) 2002-05-15
EP0771206A1 (en) 1997-05-07
NZ290219A (en) 1998-06-26
FI970202A7 (fi) 1997-01-17
CZ14097A3 (en) 1997-07-16
BR9508322A (pt) 1998-01-06
DE69527203T2 (de) 2003-01-09
NO970215L (no) 1997-01-17
AU696183B2 (en) 1998-09-03

Similar Documents

Publication Publication Date Title
ES2178675T3 (es) Agente estimulante del tejido duro.
ATE238020T1 (de) Hautpflegezusammensetzungen und methode für die verbesserung des hautaussehens
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
ES2020890A6 (es) Procedimiento de preparacion de una composicion farmaceutica en forma de microparticulas.
JP2012001548A (ja) 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法
SI1007089T1 (sl) Antikoagulantska humanizirana protitelesa proti faktorju IX za uporabo pri zdravljenju tromboze
AU2001291687A1 (en) Polyammonium-polysiloxane compounds, methods for the production and use thereof
ES2180649T3 (es) Agente antiadherente.
BR9305783A (pt) Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água
ES2170770T3 (es) Utilizacion de isovaleramida como ansiolitico suave y agente sedante suave.
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
AU5641798A (en) Artificial antibodies, method of producing the same and use thereof
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
EP0971725A4 (en) METHOD FOR TREATING SCAR TISSUE
DE59002772D1 (de) Verwendung von Dextransulfat, gegebenenfalls in Kombination mit anti-androgenen Mitteln zur Behandlung des humanen Protatakarzinoms.
IT1293088B1 (it) Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
GB9426012D0 (en) Mobilisation of haematopoietic cells
AU6901191A (en) Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
EP0631617A4 (en) Puzzling cell mitogen in the colon, cell line that makes it and uses.
AU7980798A (en) Chemically modified a-macroglobulins, methods of making, and methods of using the same in anti-cytokine therapy
GB9723824D0 (en) Cytostatic agents